Huangbing Wu

发表

Circulating Thrombospondin-2 enhances prediction of malignant intraductal papillary mucinous neoplasm.

M. Korc, C. Schmidt, M. Yip-Schneider, 2019, American journal of surgery.

Novel expression of vascular endothelial growth factor isoforms in the pancreas and pancreatic cystic lesions.

C. Schmidt, M. Yip-Schneider, Huangbing Wu, 2020, Biochimie.

Pancreatic cyst fluid VEGF-A and CEA : a highly accurate test for the diagnosis of serous cystic neoplasm

Hancock, M. Radovich, Scott C. Dolejs, 2018 .

Pancreatic Cyst Fluid Vascular Endothelial Growth Factor A and Carcinoembryonic Antigen: A Highly Accurate Test for the Diagnosis of Serous Cystic Neoplasm.

M. Radovich, Scott C. Dolejs, C. Schmidt, 2017, Journal of the American College of Surgeons.

Circulating Leptin and Branched Chain Amino Acids—Correlation with Intraductal Papillary Mucinous Neoplasm Dysplastic Grade

M. Korc, C. Schmidt, M. Yip-Schneider, 2018, Journal of Gastrointestinal Surgery.

Alcohol induces liver neoplasia in a novel alcohol-preferring rat model.

I. McKillop, K. Sandrasegaran, C. Schmidt, 2011, Alcoholism, clinical and experimental research.

Performance of candidate urinary biomarkers for pancreatic cancer - Correlation with pancreatic cyst malignant progression?

C. Schmidt, M. Yip-Schneider, Huangbing Wu, 2020, American journal of surgery.

Pancreatic cyst fluid glucose: rapid, inexpensive, and accurate diagnosis of mucinous pancreatic cysts

Walter G. Park, Scott C. Dolejs, E. Ceppa, 2017, Surgery.

Prostaglandin E2: A Pancreatic Fluid Biomarker of Intraductal Papillary Mucinous Neoplasm Dysplasia.

C. Schmidt, M. Yip-Schneider, C. M. Schmidt, 2017, Journal of the American College of Surgeons.

Tailored α-methylene-γ-butyrolactones and their effects on growth suppression in pancreatic carcinoma cells.

P. Ramachandran, C. Schmidt, M. Yip-Schneider, 2010, Bioorganic & medicinal chemistry letters.

Suppression of pancreatic tumor growth by combination chemotherapy with sulindac and LC-1 is associated with cyclin D1 inhibition in vivo

C. Yiannoutsos, P. Crooks, H. Nakshatri, 2007, Molecular Cancer Therapeutics.

Targeting MEK is Effective Chemoprevention of Hepatocellular Carcinoma in TGF-α-Transgenic Mice

J. Sebolt-Leopold, C. Schmidt, M. Yip-Schneider, 2007, Journal of Gastrointestinal Surgery.

A Quantitative Global Proteomics Approach Identifies Candidate Urinary Biomarkers That Correlate With Intraductal Papillary Mucinous Neoplasm Dysplasia

A. Mosley, J. DeWitt, C. Schmidt, 2020, Pancreas.

Pancreatic Fluid Interleukin-1β Complements Prostaglandin E2 and Serum Carbohydrate Antigen 19-9 in Prediction of Intraductal Papillary Mucinous Neoplasm Dysplasia.

C. Schmidt, M. Yip-Schneider, R. Simpson, 2019, Pancreas.

Vascular endothelial growth factor, a novel and highly accurate pancreatic fluid biomarker for serous pancreatic cysts.

Narasimhan P. Agaram, M. Radovich, C. Schmidt, 2014, Journal of the American College of Surgeons.

Efficacy of Dimethylaminoparthenolide and Sulindac in Combination With Gemcitabine in a Genetically Engineered Mouse Model of Pancreatic Cancer

R. Hruban, P. Crooks, A. Lowy, 2013, Pancreas.

Effect of Celecoxib and the Novel Anti-Cancer Agent, Dimethylamino-Parthenolide, in a Developmental Model of Pancreatic Cancer

P. Crooks, C. Sweeney, M. Yip-Schneider, 2008, Pancreas.

Insulin‐like growth factor‐I protects granule neurons from apoptosis and improves ataxia in weaver mice

P. Ye, Wei-Hua Lee, Jennifer Phan, 2005, Journal of neuroscience research.

Effect of celecoxib and novel agent LC-1 in a hamster model of lung cancer.

P. Crooks, H. Nakshatri, C. Sweeney, 2007, The Journal of surgical research.

Amplification-Free, High-Throughput Nanoplasmonic Quantification of Circulating MicroRNAs in Unprocessed Plasma Microsamples for Earlier Pancreatic Cancer Detection.

R. Sardar, M. Fishel, M. Yip-Schneider, 2023, ACS sensors.

Dimethylaminoparthenolide and gemcitabine: a survival study using a genetically engineered mouse model of pancreatic cancer

Narasimhan P. Agaram, P. Crooks, C. Schmidt, 2013, BMC Cancer.

Targeting mitogen‐activated protein kinase kinase with the inhibitor PD0325901 decreases hepatocellular carcinoma growth in vitro and in mouse model systems

C. Schmidt, M. Yip-Schneider, Huangbing Wu, 2010, Hepatology.

Ethanol-TGFalpha-MEK signaling promotes growth of human hepatocellular carcinoma.

I. McKillop, C. Schmidt, M. Yip-Schneider, 2009, The Journal of surgical research.

Erratum: Suppression of pancreatic tumor growth by combination chemotherapy with sulindac and LC-1 is associated with cyclin D1 inhibition in vivo (Molecular Cancer Therapeutics (2007) 6, (1736-1744))

C. Yiannoutsos, P. Crooks, H. Nakshatri, 2007, Molecular Cancer Therapeutics.

Targeting MEK is effective chemoprevention of hepatocellular carcinoma in TGF-alpha-transgenic mice.

J. Sebolt-Leopold, C. Schmidt, M. Yip-Schneider, 2008, Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract.

Circulating thrombospondin-2 enhances prediction of malignant intraductal papillary mucinous neoplasm.

M. Korc, M. Yip-Schneider, R. Simpson, 2019, American Journal of Surgery.

Ethanol-TGFalpha-MEK signaling promotes growth of human hepatocellular carcinoma.

I. McKillop, M. Yip-Schneider, Huangbing Wu, 2009, The Journal of surgical research.

Alcohol induces liver neoplasia in a novel alcohol-preferring rat model.

Joshua A. Waters, I. McKillop, K. Sandrasegaran, 2011, Alcoholism, clinical and experimental research.